HEADER TRANSFERASE 30-DEC-01 1KP9 TITLE CRYSTAL STRUCTURE OF MYCOLIC ACID CYCLOPROPANE SYNTHASE CMAA1, APO- TITLE 2 FORM COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLOPROPANE-FATTY-ACYL-PHOSPHOLIPID SYNTHASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CYCLOPROPANE FATTY ACID SYNTHASE; CFA SYNTHASE; CYCLOPROPANE COMPND 5 MYCOLIC ACID SYNTHASE; CMAA1; COMPND 6 EC: 2.1.1.79; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 GENE: CMAA1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PET; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET30B(CMAA1) KEYWDS MIXED ALPHA BETA FOLD, STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE KEYWDS 2 INITIATIVE, TB STRUCTURAL GENOMICS CONSORTIUM, TBSGC, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.-C.HUANG,C.V.SMITH,W.R.JACOBS JR.,M.S.GLICKMAN,J.C.SACCHETTINI,TB AUTHOR 2 STRUCTURAL GENOMICS CONSORTIUM (TBSGC) REVDAT 5 14-FEB-24 1KP9 1 REMARK REVDAT 4 24-FEB-09 1KP9 1 VERSN REVDAT 3 01-FEB-05 1KP9 1 JRNL AUTHOR KEYWDS REMARK REVDAT 2 08-APR-02 1KP9 1 JRNL REVDAT 1 11-JAN-02 1KP9 0 JRNL AUTH C.-C.HUANG,C.V.SMITH,M.S.GLICKMAN,W.R.JACOBS JR., JRNL AUTH 2 J.C.SACCHETTINI JRNL TITL CRYSTAL STRUCTURES OF MYCOLIC ACID CYCLOPROPANE SYNTHASES JRNL TITL 2 FROM MYCOBACTERIUM TUBERCULOSIS JRNL REF J.BIOL.CHEM. V. 277 11559 2002 JRNL REFN ISSN 0021-9258 JRNL PMID 11756461 JRNL DOI 10.1074/JBC.M111698200 REMARK 2 REMARK 2 RESOLUTION. 2.21 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : CNS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.21 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.29 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 330464.750 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 83.0 REMARK 3 NUMBER OF REFLECTIONS : 22287 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.800 REMARK 3 FREE R VALUE TEST SET COUNT : 2184 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 59.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2404 REMARK 3 BIN R VALUE (WORKING SET) : 0.2420 REMARK 3 BIN FREE R VALUE : 0.3040 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 241 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4288 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 12 REMARK 3 SOLVENT ATOMS : 193 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.62000 REMARK 3 B22 (A**2) : -0.51000 REMARK 3 B33 (A**2) : 1.13000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 7.77000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.23 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.32 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.720 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.450 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.390 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.040 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.920 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.30 REMARK 3 BSOL : 29.27 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : OAC.PAR REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : OAC.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1KP9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JAN-02. REMARK 100 THE DEPOSITION ID IS D_1000015195. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-FEB-01 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : OSMIC MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MACSCIENCE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23312 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.4 REMARK 200 DATA REDUNDANCY : 1.940 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06200 REMARK 200 FOR THE DATA SET : 17.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 73.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.18300 REMARK 200 FOR SHELL : 4.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, SODIUM ACETATE, MES , REMARK 280 AMMONIUM ACETATE, 1,6-HEXADIOL, PH 6.5, EVAPORATION AT 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.90600 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 ASP A 3 REMARK 465 GLU A 4 REMARK 465 LEU A 5 REMARK 465 LYS A 6 REMARK 465 PRO A 7 REMARK 465 HIS A 8 REMARK 465 PHE A 9 REMARK 465 ALA A 10 REMARK 465 ASN A 11 REMARK 465 VAL A 12 REMARK 465 GLN A 13 REMARK 465 ALA A 14 REMARK 465 HIS A 15 REMARK 465 TYR A 16 REMARK 465 ASP A 17 REMARK 465 MET B 1 REMARK 465 PRO B 2 REMARK 465 ASP B 3 REMARK 465 GLU B 4 REMARK 465 LEU B 5 REMARK 465 LYS B 6 REMARK 465 PRO B 7 REMARK 465 HIS B 8 REMARK 465 PHE B 9 REMARK 465 ALA B 10 REMARK 465 ASN B 11 REMARK 465 VAL B 12 REMARK 465 GLN B 13 REMARK 465 ALA B 14 REMARK 465 HIS B 15 REMARK 465 TYR B 16 REMARK 465 ASP B 17 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 33 58.80 -98.65 REMARK 500 ASP A 87 67.41 37.46 REMARK 500 ASN A 112 130.65 -37.19 REMARK 500 LEU A 113 30.75 -74.88 REMARK 500 PHE A 139 -95.25 -37.40 REMARK 500 GLU A 140 4.62 -52.83 REMARK 500 ARG A 156 3.21 -65.77 REMARK 500 ILE A 177 -126.81 -42.52 REMARK 500 HIS A 178 143.52 89.05 REMARK 500 ILE A 199 -68.15 -121.37 REMARK 500 SER A 216 6.77 -67.35 REMARK 500 ASN A 218 10.66 -144.79 REMARK 500 VAL A 222 97.94 -62.71 REMARK 500 GLN A 254 -103.19 -115.72 REMARK 500 ASP B 41 -18.00 -49.19 REMARK 500 HIS B 144 15.47 -161.67 REMARK 500 ARG B 146 31.05 -94.60 REMARK 500 ILE B 199 -74.59 -131.94 REMARK 500 ARG B 224 142.09 -170.05 REMARK 500 GLN B 254 -106.87 -99.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY B 288 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY A 288 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY B 289 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1KPG RELATED DB: PDB REMARK 900 RELATED ID: 1KPH RELATED DB: PDB REMARK 900 RELATED ID: 1KPI RELATED DB: PDB REMARK 900 RELATED ID: RV3392C RELATED DB: TARGETDB DBREF 1KP9 A 1 287 UNP Q11195 CFA1_MYCTU 1 287 DBREF 1KP9 B 1 287 UNP Q11195 CFA1_MYCTU 1 287 SEQRES 1 A 287 MET PRO ASP GLU LEU LYS PRO HIS PHE ALA ASN VAL GLN SEQRES 2 A 287 ALA HIS TYR ASP LEU SER ASP ASP PHE PHE ARG LEU PHE SEQRES 3 A 287 LEU ASP PRO THR GLN THR TYR SER CYS ALA TYR PHE GLU SEQRES 4 A 287 ARG ASP ASP MET THR LEU GLN GLU ALA GLN ILE ALA LYS SEQRES 5 A 287 ILE ASP LEU ALA LEU GLY LYS LEU GLY LEU GLN PRO GLY SEQRES 6 A 287 MET THR LEU LEU ASP VAL GLY CYS GLY TRP GLY ALA THR SEQRES 7 A 287 MET MET ARG ALA VAL GLU LYS TYR ASP VAL ASN VAL VAL SEQRES 8 A 287 GLY LEU THR LEU SER LYS ASN GLN ALA ASN HIS VAL GLN SEQRES 9 A 287 GLN LEU VAL ALA ASN SER GLU ASN LEU ARG SER LYS ARG SEQRES 10 A 287 VAL LEU LEU ALA GLY TRP GLU GLN PHE ASP GLU PRO VAL SEQRES 11 A 287 ASP ARG ILE VAL SER ILE GLY ALA PHE GLU HIS PHE GLY SEQRES 12 A 287 HIS GLU ARG TYR ASP ALA PHE PHE SER LEU ALA HIS ARG SEQRES 13 A 287 LEU LEU PRO ALA ASP GLY VAL MET LEU LEU HIS THR ILE SEQRES 14 A 287 THR GLY LEU HIS PRO LYS GLU ILE HIS GLU ARG GLY LEU SEQRES 15 A 287 PRO MET SER PHE THR PHE ALA ARG PHE LEU LYS PHE ILE SEQRES 16 A 287 VAL THR GLU ILE PHE PRO GLY GLY ARG LEU PRO SER ILE SEQRES 17 A 287 PRO MET VAL GLN GLU CYS ALA SER ALA ASN GLY PHE THR SEQRES 18 A 287 VAL THR ARG VAL GLN SER LEU GLN PRO HIS TYR ALA LYS SEQRES 19 A 287 THR LEU ASP LEU TRP SER ALA ALA LEU GLN ALA ASN LYS SEQRES 20 A 287 GLY GLN ALA ILE ALA LEU GLN SER GLU GLU VAL TYR GLU SEQRES 21 A 287 ARG TYR MET LYS TYR LEU THR GLY CYS ALA GLU MET PHE SEQRES 22 A 287 ARG ILE GLY TYR ILE ASP VAL ASN GLN PHE THR CYS GLN SEQRES 23 A 287 LYS SEQRES 1 B 287 MET PRO ASP GLU LEU LYS PRO HIS PHE ALA ASN VAL GLN SEQRES 2 B 287 ALA HIS TYR ASP LEU SER ASP ASP PHE PHE ARG LEU PHE SEQRES 3 B 287 LEU ASP PRO THR GLN THR TYR SER CYS ALA TYR PHE GLU SEQRES 4 B 287 ARG ASP ASP MET THR LEU GLN GLU ALA GLN ILE ALA LYS SEQRES 5 B 287 ILE ASP LEU ALA LEU GLY LYS LEU GLY LEU GLN PRO GLY SEQRES 6 B 287 MET THR LEU LEU ASP VAL GLY CYS GLY TRP GLY ALA THR SEQRES 7 B 287 MET MET ARG ALA VAL GLU LYS TYR ASP VAL ASN VAL VAL SEQRES 8 B 287 GLY LEU THR LEU SER LYS ASN GLN ALA ASN HIS VAL GLN SEQRES 9 B 287 GLN LEU VAL ALA ASN SER GLU ASN LEU ARG SER LYS ARG SEQRES 10 B 287 VAL LEU LEU ALA GLY TRP GLU GLN PHE ASP GLU PRO VAL SEQRES 11 B 287 ASP ARG ILE VAL SER ILE GLY ALA PHE GLU HIS PHE GLY SEQRES 12 B 287 HIS GLU ARG TYR ASP ALA PHE PHE SER LEU ALA HIS ARG SEQRES 13 B 287 LEU LEU PRO ALA ASP GLY VAL MET LEU LEU HIS THR ILE SEQRES 14 B 287 THR GLY LEU HIS PRO LYS GLU ILE HIS GLU ARG GLY LEU SEQRES 15 B 287 PRO MET SER PHE THR PHE ALA ARG PHE LEU LYS PHE ILE SEQRES 16 B 287 VAL THR GLU ILE PHE PRO GLY GLY ARG LEU PRO SER ILE SEQRES 17 B 287 PRO MET VAL GLN GLU CYS ALA SER ALA ASN GLY PHE THR SEQRES 18 B 287 VAL THR ARG VAL GLN SER LEU GLN PRO HIS TYR ALA LYS SEQRES 19 B 287 THR LEU ASP LEU TRP SER ALA ALA LEU GLN ALA ASN LYS SEQRES 20 B 287 GLY GLN ALA ILE ALA LEU GLN SER GLU GLU VAL TYR GLU SEQRES 21 B 287 ARG TYR MET LYS TYR LEU THR GLY CYS ALA GLU MET PHE SEQRES 22 B 287 ARG ILE GLY TYR ILE ASP VAL ASN GLN PHE THR CYS GLN SEQRES 23 B 287 LYS HET ACY A 288 4 HET ACY B 288 4 HET ACY B 289 4 HETNAM ACY ACETIC ACID FORMUL 3 ACY 3(C2 H4 O2) FORMUL 6 HOH *193(H2 O) HELIX 1 1 SER A 19 LEU A 25 1 7 HELIX 2 2 THR A 44 GLY A 58 1 15 HELIX 3 3 GLY A 76 ASP A 87 1 12 HELIX 4 4 SER A 96 ALA A 108 1 13 HELIX 5 5 GLY A 122 PHE A 126 5 5 HELIX 6 6 ARG A 146 ARG A 156 1 11 HELIX 7 7 SER A 185 ILE A 199 1 15 HELIX 8 8 SER A 207 SER A 216 1 10 HELIX 9 9 LEU A 228 ASN A 246 1 19 HELIX 10 10 ASN A 246 GLN A 254 1 9 HELIX 11 11 SER A 255 ILE A 275 1 21 HELIX 12 12 SER B 19 LEU B 25 1 7 HELIX 13 13 THR B 44 GLY B 58 1 15 HELIX 14 14 GLY B 76 ASP B 87 1 12 HELIX 15 15 SER B 96 SER B 110 1 15 HELIX 16 16 GLY B 122 PHE B 126 5 5 HELIX 17 17 ARG B 146 LEU B 158 1 13 HELIX 18 18 LYS B 175 ARG B 180 1 6 HELIX 19 19 SER B 185 ILE B 199 1 15 HELIX 20 20 SER B 207 ASN B 218 1 12 HELIX 21 21 LEU B 228 ASN B 246 1 19 HELIX 22 22 ASN B 246 GLN B 254 1 9 HELIX 23 23 SER B 255 ILE B 275 1 21 SHEET 1 A 7 LYS A 116 LEU A 119 0 SHEET 2 A 7 ASN A 89 LEU A 93 1 N GLY A 92 O LEU A 119 SHEET 3 A 7 THR A 67 VAL A 71 1 N LEU A 68 O VAL A 91 SHEET 4 A 7 ARG A 132 ILE A 136 1 O VAL A 134 N LEU A 69 SHEET 5 A 7 VAL A 163 GLY A 171 1 O HIS A 167 N SER A 135 SHEET 6 A 7 ILE A 278 GLN A 286 -1 O ASP A 279 N THR A 170 SHEET 7 A 7 THR A 221 SER A 227 -1 N GLN A 226 O GLN A 282 SHEET 1 B 7 LYS B 116 LEU B 120 0 SHEET 2 B 7 ASN B 89 THR B 94 1 N GLY B 92 O ARG B 117 SHEET 3 B 7 THR B 67 VAL B 71 1 N ASP B 70 O VAL B 91 SHEET 4 B 7 ARG B 132 ILE B 136 1 O VAL B 134 N LEU B 69 SHEET 5 B 7 VAL B 163 GLY B 171 1 O HIS B 167 N SER B 135 SHEET 6 B 7 ILE B 278 GLN B 286 -1 O ASP B 279 N THR B 170 SHEET 7 B 7 THR B 221 SER B 227 -1 N THR B 221 O GLN B 286 CISPEP 1 PHE A 200 PRO A 201 0 0.04 CISPEP 2 PHE B 200 PRO B 201 0 0.30 SITE 1 AC1 6 SER B 34 CYS B 35 GLY B 137 HIS B 167 SITE 2 AC1 6 ILE B 169 TYR B 232 SITE 1 AC2 8 SER A 34 CYS A 35 GLY A 137 PHE A 139 SITE 2 AC2 8 HIS A 167 ILE A 169 TYR A 232 HOH A1045 SITE 1 AC3 5 PRO B 29 THR B 30 GLN B 31 HIS B 102 SITE 2 AC3 5 HOH B1154 CRYST1 50.342 73.812 76.043 90.00 107.07 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019864 0.000000 0.006100 0.00000 SCALE2 0.000000 0.013548 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013756 0.00000